Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Targeting RAGE Signaling in Inflammatory Disease.

Hudson BI, Lippman ME.

Annu Rev Med. 2018 Jan 29;69:349-364. doi: 10.1146/annurev-med-041316-085215. Epub 2017 Nov 6.

PMID:
29106804
2.

Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.

Miller P, Kidwell KM, Thomas D, Sabel M, Rae JM, Hayes DF, Hudson BI, El-Ashry D, Lippman ME.

Breast Cancer Res Treat. 2017 Nov;166(1):85-94. doi: 10.1007/s10549-017-4366-6. Epub 2017 Jul 17.

PMID:
28717852
3.

Associations of hyperglycemia and insulin resistance with biomarkers of endothelial dysfunction in Hispanic/Latino youths: Results from the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth).

Parrinello CM, Hua S, Carnethon MR, Gallo LC, Hudson BI, Goldberg RB, Delamater AM, Kaplan RC, Isasi CR.

J Diabetes Complications. 2017 May;31(5):836-842. doi: 10.1016/j.jdiacomp.2017.01.019. Epub 2017 Feb 9.

4.

Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis.

Kwak T, Drews-Elger K, Ergonul A, Miller PC, Braley A, Hwang GH, Zhao D, Besser A, Yamamoto Y, Yamamoto H, El-Ashry D, Slingerland JM, Lippman ME, Hudson BI.

Oncogene. 2017 Mar;36(11):1559-1572. doi: 10.1038/onc.2016.324. Epub 2016 Sep 26.

PMID:
27669433
5.

Subfractions of High-Density Lipoprotein-Cholesterol and Carotid Intima-Media Thickness: The Northern Manhattan Study.

Tiozzo E, Gardener H, Hudson BI, Dong C, Della-Morte D, Crisby M, Goldberg RB, Elkind MS, Cheung YK, Wright CB, Sacco RL, Desvarieux M, Rundek T.

Stroke. 2016 Jun;47(6):1508-13. doi: 10.1161/STROKEAHA.115.012009. Epub 2016 May 10.

6.

Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function.

Braley A, Kwak T, Jules J, Harja E, Landgraf R, Hudson BI.

J Biol Chem. 2016 Jun 3;291(23):12057-73. doi: 10.1074/jbc.M115.702399. Epub 2016 Mar 28.

7.

Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study.

Shah NH, Dong C, Elkind MS, Sacco RL, Mendez AJ, Hudson BI, Silverberg S, Wolf M, Rundek T, Wright CB.

Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):2048-53. doi: 10.1161/ATVBAHA.115.305945. Epub 2015 Jun 25.

8.

Serum soluble RAGE levels and carotid atherosclerosis: the Northern Manhattan Study (NOMAS).

Hudson BI, Gardener H, Liu-Mares W, Dong C, Cheung K, Elkind MS, Wright CB, Sacco RL, Rundek T.

Atherosclerosis. 2015 May;240(1):17-20. doi: 10.1016/j.atherosclerosis.2015.02.015. Epub 2015 Feb 24.

9.

High-density lipoprotein subfractions and carotid plaque: the Northern Manhattan Study.

Tiozzo E, Gardener H, Hudson BI, Dong C, Della-Morte D, Crisby M, Goldberg RB, Elkind MS, Cheung YK, Wright CB, Sacco RL, Rundek T.

Atherosclerosis. 2014 Nov;237(1):163-8. doi: 10.1016/j.atherosclerosis.2014.09.002. Epub 2014 Sep 9.

10.

Serum levels of soluble receptor for advanced glycation end-products and metabolic syndrome: the Northern Manhattan Study.

Hudson BI, Dong C, Gardener H, Elkind MS, Wright CB, Goldberg R, Sacco RL, Rundek T.

Metabolism. 2014 Sep;63(9):1125-30. doi: 10.1016/j.metabol.2014.05.011. Epub 2014 Jun 4.

11.

Alternative splicing of the RAGE cytoplasmic domain regulates cell signaling and function.

Jules J, Maiguel D, Hudson BI.

PLoS One. 2013 Nov 8;8(11):e78267. doi: 10.1371/journal.pone.0078267. eCollection 2013.

12.

RAGE binds C1q and enhances C1q-mediated phagocytosis.

Ma W, Rai V, Hudson BI, Song F, Schmidt AM, Barile GR.

Cell Immunol. 2012;274(1-2):72-82. doi: 10.1016/j.cellimm.2012.02.001. Epub 2012 Feb 13.

PMID:
22386596
13.

Alternative splicing of RAGE: roles in biology and disease.

Kalea AZ, Schmidt AM, Hudson BI.

Front Biosci (Landmark Ed). 2011 Jun 1;16:2756-70. Review.

PMID:
21622207
14.

Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS).

Hudson BI, Moon YP, Kalea AZ, Khatri M, Marquez C, Schmidt AM, Paik MC, Yoshita M, Sacco RL, DeCarli C, Wright CB, Elkind MS.

Atherosclerosis. 2011 May;216(1):192-8. doi: 10.1016/j.atherosclerosis.2011.01.024. Epub 2011 Jan 21.

15.

Receptor for advanced glycation endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cells.

Pollreisz A, Hudson BI, Chang JS, Qu W, Cheng B, Papapanou PN, Schmidt AM, Lalla E.

Atherosclerosis. 2010 Oct;212(2):451-6. doi: 10.1016/j.atherosclerosis.2010.07.011. Epub 2010 Jul 21.

16.

Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signaling.

Kalea AZ, See F, Harja E, Arriero M, Schmidt AM, Hudson BI.

Cancer Res. 2010 Jul 1;70(13):5628-38. doi: 10.1158/0008-5472.CAN-10-0595. Epub 2010 Jun 22.

17.

Kansuinine A and Kansuinine B from Euphorbia kansui L. inhibit IL-6-induced Stat3 activation.

Chang JS, Lee SW, Park MH, Kim MS, Hudson BI, Park SJ, Lee WS, Rho MC.

Planta Med. 2010 Oct;76(14):1544-9. doi: 10.1055/s-0030-1249805. Epub 2010 Apr 8.

PMID:
20379953
18.

Inflammatory stress in primary venous and aortic endothelial cells of type 1 diabetic mice.

Bucciarelli LG, Pollreisz A, Kebschull M, Ganda A, Kalea AZ, Hudson BI, Zou YS, Lalla E, Ramasamy R, Colombo PC, Schmidt AM, Yan SF.

Diab Vasc Dis Res. 2009 Oct;6(4):249-61. doi: 10.1177/1479164109338775.

PMID:
20368219
19.

Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.

Tekabe Y, Li Q, Rosario R, Sedlar M, Majewski S, Hudson BI, Einstein AJ, Schmidt AM, Johnson LL.

Circ Cardiovasc Imaging. 2008 Nov;1(3):212-9. doi: 10.1161/CIRCIMAGING.108.788299.

PMID:
19808545
20.

Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases.

Maillard-Lefebvre H, Boulanger E, Daroux M, Gaxatte C, Hudson BI, Lambert M.

Rheumatology (Oxford). 2009 Oct;48(10):1190-6. doi: 10.1093/rheumatology/kep199. Epub 2009 Jul 9. Review.

PMID:
19589888

Supplemental Content

Loading ...
Support Center